Investing Ideas
/
Chinese Pharmaceuticals & Biotech High Insider Buying

Chinese Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Pharmaron Beijing

Market Cap: CN¥48.1b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

300759

CN¥28.80

21.7%

17.4%